Search

everythinglearnresearchcommunity

for

Search:↓

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Low-dose oral minoxidil is safe for treating children's hair disorders.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Teak leaf extract hair tonic was tested for hair growth and safety.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Social media can help compare the effectiveness and safety of new arthritis medications.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

The shampoo with salicylic acid, panthenol, and niacinamide is effective and safe for preventing hair loss in people with alopecia.

The supplement may help hair growth and is safe, but more research is needed.

The herbal extract is as effective and safe as 3% minoxidil for treating hair loss.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Fullerenes show potential in skin care but need more safety research.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.